Pharmaceutical News

RSS

UTI treatment with antibiotics for older adults may be more harmful than previously thought

In a new research paper published in the Journal of the American Geriatrics Society, Thomas E. Finucane, MD, of the Johns Hopkins Geriatrics Center at Johns Hopkins in Baltimore, suggests that prescribing antibiotics for urinary tract infections (or "UTIs") may often be avoided among older adults.

2 Jun 2017

Patients nearing end of life may not feel abandoned after discontinuation of cholesterol medications

New research suggests patients nearing the end of their lives because of a "life-limiting illness" such as cancer or heart disease may not feel medically abandoned if their doctor wants to take them off the statins that control their cholesterol.

2 Jun 2017

Assessing safety and toxicity of bioactives could be key to establishing tolerable upper intake levels

The good news is out that wine and dark chocolate may be good for your health. That's because of substances known as bioactives that are contained in those foods.

2 Jun 2017

UCSB biologists develop new antimicrobial susceptibility test to transform the way antibiotics are tested

When a patient is prescribed the wrong antibiotic to treat a bacterial infection, it's not necessarily the physician who is at fault. The current antibiotic assay -- standardized in 1961 by the World Health Organization and used worldwide -- is potentially flawed.

2 Jun 2017

Antidepressant use during pregnancy not linked to newborn problems at 2-4 weeks after birth

Babies exposed to an antidepressant or a mood disorder during fetal life did not have any more signs of irritability, difficulty feeding, sleep disturbances and respiratory problems two to four weeks after birth than babies who were not exposed.

1 Jun 2017

Study reveals key role of gut microbiota in treatment with classic diabetes medication

A clearer picture of how the classic diabetes medication metformin works has emerged. A recent study at Sahlgrenska Academy and University of Girona indicates that the clinical effect - control of blood glucose - is achieved through modulation of the gut microbiota.

1 Jun 2017

Study finds decline in rates of HPV-related precancerous cervical lesions among women in Connecticut

The vaccine for the Human Papillomavirus is proving to have significant population-level effects in Connecticut, with rates of precancerous lesions caused by HPV down drastically among young women, a new Yale School of Public Health study finds.

31 May 2017

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center

31 May 2017

Dutch scientists design self-destroying nanomotors to deliver and release drugs

Autonomous targeting and release of drugs at their site of action are desired features of nanomedical systems. Now, a team of Dutch scientists has designed a nanomotor that has these functions: An antitumor drug encapsulated in self-propelled, self-assembled stomatocytes is carried across the cellular membrane and released inside the cell upon a chemical redox signal that disassembles the vesicle membrane.

31 May 2017

Oxytocin treatment may help overcome drug addiction, study suggests

Many people have suggested that addiction hijacks the body's natural drives in the service of compulsive drug use.

31 May 2017

Study finds opioid dependence and overdose rates after urologic surgery

About 1 in 1,111 patients who undergo urologic surgery for conditions such as prostate cancer and kidney stones experience opioid dependence or overdose (ODO), a Loyola Medicine study has found.

30 May 2017

First generic version of drug to treat ADHD receives FDA approval

The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.

30 May 2017

Fixed-dose combination therapy for high blood pressure linked to lower health services costs

About half of patients diagnosed with high blood pressure will need their medication adjusted within the first year to address side effects or failure to control blood pressure properly.

30 May 2017

Drug rebates reward industry players — and often hurt patients

Medicare and its beneficiaries aren't the winners in the behind-the-scenes rebate game played by drugmakers, health insurers and pharmacy benefit managers, according to a paper published Tuesday in JAMA Internal Medicine.

30 May 2017

TSRI scientists give new superpowers to lifesaving antibiotic

Scientists at The Scripps Research Institute have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come.

30 May 2017

Quitting methamphetamine use can prevent drug-related heart damage

Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical treatment, potentially preventing future drug-related cases of heart failure or other worse outcomes, according to a study published today in JACC: Heart Failure.

30 May 2017

Beta blockers may not benefit some heart attack patients

New research challenges established medical practice that all heart attack patients should be on beta blockers.

30 May 2017

Children suffering from IBD not meeting daily recommended intake of calcium and vitamin D

A new study highlights that children suffering from inflammatory bowel disease (IBD) are not meeting the daily recommended intake of calcium and vitamin D. The research, conducted at Great Ormond Street Hospital for Children in London, identified that only 26.6% and 21.3% of paediatric IBD patients were achieving the current recommended intake for calcium and vitamin D respectively.

29 May 2017

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application for SUN-101/eFlow (glycopyrrolate) for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema

27 May 2017

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.

27 May 2017

Pharmaceutical News

UTI treatment with antibiotics for older adults may be more harmful than previously thought

Patients nearing end of life may not feel abandoned after discontinuation of cholesterol medications

Assessing safety and toxicity of bioactives could be key to establishing tolerable upper intake levels

UCSB biologists develop new antimicrobial susceptibility test to transform the way antibiotics are tested

Antidepressant use during pregnancy not linked to newborn problems at 2-4 weeks after birth

Study reveals key role of gut microbiota in treatment with classic diabetes medication

Study finds decline in rates of HPV-related precancerous cervical lesions among women in Connecticut

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Dutch scientists design self-destroying nanomotors to deliver and release drugs

Oxytocin treatment may help overcome drug addiction, study suggests

Study finds opioid dependence and overdose rates after urologic surgery

First generic version of drug to treat ADHD receives FDA approval

Fixed-dose combination therapy for high blood pressure linked to lower health services costs

Drug rebates reward industry players — and often hurt patients

TSRI scientists give new superpowers to lifesaving antibiotic

Quitting methamphetamine use can prevent drug-related heart damage

Beta blockers may not benefit some heart attack patients

Children suffering from IBD not meeting daily recommended intake of calcium and vitamin D

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News